MARKET

VERO

VERO

Venus Concept Inc
NASDAQ
0.6910
-0.0290
-4.03%
After Hours: 0.6565 -0.0345 -4.99% 17:44 03/28 EDT
OPEN
0.7570
PREV CLOSE
0.7200
HIGH
0.7570
LOW
0.6800
VOLUME
36.72K
TURNOVER
0
52 WEEK HIGH
4.700
52 WEEK LOW
0.6015
MARKET CAP
4.39M
P/E (TTM)
-0.0993
1D
5D
1M
3M
1Y
5Y
Venus Concept Q4 2023 Earnings Preview
Venus Concept (NASDAQ:VERO) is scheduled to announce Q4 earnings results on Monday, April 1st. The consensus EPS estimate is -$0.87 and the consensus Revenue Estimate is $22.44M. Over the last 2 years, VERO has beaten EPS estimates 50% of the time.
Seeking Alpha · 15h ago
Weekly Report: what happened at VERO last week (0318-0322)?
Weekly Report · 3d ago
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
Venus Concept Inc. Received a decision from the Nasdaq Hearings Panel granting its request for continued listing on the NasDAQ Capital Market. The Nasdaq Panel decision is expected to be made on or before May 28, 2024. Venus Concept will continue to be listed on Nasdaq.
Barchart · 3d ago
Weekly Report: what happened at VERO last week (0311-0315)?
Weekly Report · 03/18 11:00
Venus Concept Launches “NEXThetics” Program
Venus Concept Inc. Announces launch of new series of customer education and training events. NEXThetics events provide professionals from all sectors of the aesthetics industry a networking opportunity. The company is a global medical aesthetic technology leader. NEX thetics is the newest advancement under the company's rebranding.
Barchart · 03/12 15:05
Weekly Report: what happened at VERO last week (0304-0308)?
Weekly Report · 03/11 10:57
Weekly Report: what happened at VERO last week (0226-0301)?
Weekly Report · 03/04 11:00
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Venus Concept Inc. Has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules. The Company issued 817,748 shares of common stock at a purchase price of $1.465 per share. Venus Concept is a global medical aesthetic technology leader.
Barchart · 02/27 15:05
More
About VERO
Venus Concept Inc. is a global medical aesthetic technology company. The Company has a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches in over 60 countries and 14 direct markets. The Company's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. The Company's systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company's hair loss treatment solutions include the ARTAS Solution and the NeoGraft Solution.

Webull offers Venus Concept Inc stock information, including NASDAQ: VERO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VERO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VERO stock methods without spending real money on the virtual paper trading platform.